HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats.

Abstract
Preclinical studies using rodent models of stroke have had difficulty in translating their results to human patients. One possible factor behind this inability is the lack of studies utilizing aged rodents of both sexes. Previously, this lab showed that leukemia inhibitory factor (LIF) promoted recovery after stroke through antioxidant enzyme upregulation. This study examined whether LIF promotes neuroprotection in aged rats of both sexes. LIF did not reduce tissue damage in aged animals, but LIF-treated female rats showed partial motor skill recovery. The LIF receptor (LIFR) showed membrane localization in young male and aged rats of both sexes after stroke. Although LIF increased neuronal LIFR expression in vitro, it did not increase LIFR in the aged brain. Levels of LIFR protein in brain tissue were significantly downregulated between young males and aged males/females at 72 h after stroke. These results demonstrated that low LIFR expression reduces the neuroprotective efficacy of LIF in aged rodents of both sexes. Furthermore, the ability of LIF to promote motor improvement is dependent upon sex in aged rodents.
AuthorsStephanie M Davis, Lisa A Collier, Sarah Goodwin, Douglas E Lukins, David K Powell, Keith R Pennypacker
JournalBrain research (Brain Res) Vol. 1707 Pg. 62-73 (03 15 2019) ISSN: 1872-6240 [Electronic] Netherlands
PMID30445025 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Cytokines
  • Interleukin-6
  • Leukemia Inhibitory Factor
  • Receptors, Cytokine
  • Receptors, OSM-LIF
Topics
  • Age Factors
  • Animals
  • Brain (metabolism)
  • Cytokines (metabolism)
  • Female
  • Interleukin-6 (metabolism)
  • Leukemia Inhibitory Factor (metabolism, pharmacology)
  • Male
  • Neurons (metabolism)
  • Neuroprotection
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cytokine (metabolism)
  • Receptors, OSM-LIF (metabolism)
  • Sex Factors
  • Stroke (drug therapy, metabolism)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: